Niuvanniemen sairaala

Julkaisut
Publications

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 2020:19(1):61-68.
2 Tiihonen J, Tanskanen A, Taipale H. 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia. Am J Psychiatry 2018:175(8):765-773.
3 Kupila J, Kärkkäinen O, Laukkanen V, Häkkinen M, Kautiainen H, Tiihonen J, Storvik M. (3H)Ifenprodil binding in post-mortem brains of cloninger type 1 and 2 alcoholics: A whole-hemisphere autoradiography study . Psychiatry Res 2015:231(3):197-201.
4 Sun L, Lukkarinen L, Noppari T, Nazari-Farsani S, Putkinen V, Seppälä K, Hudson M, Tani P, Lindberg N, Karlsson HK, Hirvonen J, Salomaa M, Venetjoki N, Lauerma H, Tiihonen J, Nummenmaa L. Aberrant motor contagion of emotions in psychopathy and high-functioning autism. Cereb Cortex 2022:33(2):374-384.
5 Koponen M, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease. J Am Med Dir Assoc 2019:20(12):1488-1494.e3.
6 Terevnikov V, Stenberg J, Tiihonen J, Burkin M, Joffe G. Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics. Nord J Psychiatry 2017:71(1):77-80.
7 Lintunen J, Lähteenvuo M, Tiihonen J, Tanskanen A, Taipale H. Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia. NPJ Schizophr 2021:7(1):1.
8 Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study. Eur J Clin Pharmacol 2019:75(10):1421-1430.
9 Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol 2016:8:363-371.
10 Lindsberg PJ, Castrén E, ..., Isometsä E, Kalso E, Marttunen M, Pihko H, Tienari P, Wartiovaara A, Jäkälä P, Kälviäinen R, Soininen H, Tiihonen J, Karlsson H, Rinne J, Roine RO, Elovaara I, Tamminen T, Öhman J, Majamaa K, Hari R. Aivosairaudet ovat kalleimmat kansantautimme. Duodecim 2014:130(17):1721-30.
11 Lehikoinen AI, Kärkkäinen OK, Lehtonen MAS, Auriola SOK, Hanhineva KJ, Heinonen ST. Alcohol and substance use are associated with altered metabolome in the first trimester serum samples of pregnant mothers . Eur J Obstet Gynecol Reprod Biol 2018:223:79-84.
12 Lintunen J, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study. J Affect Disord 2022:313:43-48.
13 Laukkanen V, Laukkanen V. Alterations in the neurotransmitter receptor binding densities in cloninger type 1 and 2 alcoholics. Doctoral dissertation. Kuopio: University of Eastern Finland, 2016. Publications of the University of Eastern Finland. Dissertations in Health Sciences 355. 76 p.
14 Taipale H, Tolppanen A-M, Purhonen M, Tanskanen A, Ahonen R, Tiihonen J, Hartikainen S. Alueelliset erot sairaalapäivissä ja lääkekustannuksissa Alzheimerin tautia sairastavilla ja verokeilla. Suomen Lääkärilehti 2016:71(22):1613-1619.
15 Juhola L, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. Alzheimer-potilaat ja psyykenlääkkeiden käyttö 2005-2011. Suomen Lääkärilehti 2019:74(10):609-616.
16 Kärkkäinen O, Kupila J, Häkkinen M, Laukkanen V, Tupala E, Kautiainen H, Tiihonen J, Storvik M. AMPA receptors in post-mortem brains of Cloninger type 1 and 2 alcoholics: A whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2013:214:429-434.
17 Kivimies K. Amphetamine, Cannabis and Opioid Use Disorders in Forensic Patients and in Schizophrenia. Doctoral dissertation. Kuopio: University of Eastern Finland, 2018. Publications of the University of Eastern Finland. Dissertations in Health Sciences 468. 52 p.
18 Lindner P, Flodin P, Larm P, Budhiraja M, Savic-Berglund I, Jokinen J, Tiihonen J, Hodgins S. Amygdala-orbitofrontal structural and functional connectivity in females with anxiety disorders, with and without a history of conduct disorder. Sci Rep 2018:8(1):1101.
19 Paljarvi T, Forton J, Luciano S, Herttua K, Fazel S. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. JAMA Netw Open 2022:5(5):e2213643.
20 Borger Rognli E, Taipale H, Hjorthøj C, Mittendorfer-Rutz E, Bramness JG, Heiberg IH, Niemelä S. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016. Psychol Med 2023:53(11):5246-5255.
21 Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study. J Alzheimers Dis 2017:56(1):119-128.
22 Taipale H1, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. Int Clin Psychopharmacol 2014:29(4):216-23.
23 Kieseppä V, Markkula N, Taipale H, Holm M, Jokela M, Suvisaari J, Tanskanen A, Gissler M, Lehti V. Antidepressant use among immigrants with depressive disorder living in Finland: A register-based study. J Affect Disord 2022:299:528-535.
24 Torvinen-Kiiskinen S, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease. Int J Geriatr Psychiatry 2017:32(12):e107-e115.
25 Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease. Neurology 2020:94(20):e2099-e2108.
26 Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A-M. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study. J Am Heart Assoc 2018:7(18):e009742.
27 Taipale H, Lampela P, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study. J Alzheimers Dis 2019:68(1):127-136.
28 Lavikainen P, Taipale H, Tanskanen A, Koponen M, Tiihonen J, Hartikainen S, Tolppanen A. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease. J Am Med Dir Assoc 2019:20(6):751-758.
29 Luykx JJ, Tiihonen J. Antipsychotic discontinuation: mind the patient and the real-world evidence. Lancet Psychiatry 2021:8(7):555-557.
30 Taipale H1, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland. J Clin Psychopharmacol 2014:34(3):435-40.
31 Taipale H1, Koponen M1, Tanskanen A2, Tolppanen AM3, Tiihonen J, Hartikainen S. Antipsychotic Polypharmacy among a Nationwide Sample of Community-Dwelling Persons with Alzheimer's Disease. J Alzheimers Dis 2014:41(4):1223-8.
32 Lähteenvuo M, Tiihonen J. Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations. Drugs 2021:81(11):1273-1284.
33 Torniainen M, Mittendorfer-Rutz E, Tanskanen A, Björkenstam C, Suvisaari J, Alexanderson K, Tiihonen J. Antipsychotic Treatment and Mortality in Schizophrenia. Schizophr Bull 2015:41(3):656-63.
34 Spaton Goppers J, Mittendorfer-Rutz E, Cullen AE, Jamil de Montgomery C, Tanskanen A, Norredam M, Taipale H. Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study. BJPsych Open 2023:9(3):e57.
35 Taipale H, Puranen A, Mittendorfer-Rutz E, Tiihonen J, Tanskanen A, Cervenka S, Lähteenvuo M. Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences. Nord J Psychiatry 2021:75(5):315-322.
36 Taipale H, Solmi M, Lähteenvuo M, Tanskanen A, Correll CU, Tiihonen J. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. Lancet Psychiatry 2021:8(10):883-891.
37 Tolppanen AM, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Taipale H. Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease. Chest 2016:150(6):1233-1241.
38 Solmi M, Lähteenvuo M, Correll CU, Tanskanen A, Tiihonen J, Taipale H. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland. Schizophr Bull 2023:49(1):78-89.
39 Koponen M, Rajamaki B, Lavikainen P, Bell JS, Taipale H, Tanskanen A, Hartikainen S, Tolppanen A. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease. J Am Med Dir Assoc 2022:23(6):1059-1065.e4.
40 Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen A, Ahonen R, Hartikainen S. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease. J Clin Psychiatry 2017:78(3):e257-e263.
41 Orsel K, Taipale H, Raatikainen S, Lampela P, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study. J Clin Psychopharmacol 2018:38(5):494-497.
42 Taipale H, Mittendorfer-Rutz E, Alexanderson K, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Tiihonen J. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res 2018:197:274-280.
43 Solmi M, Tiihonen J, Lähteenvuo M, Tanskanen A, Correll CU, Taipale H. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study. Schizophr Bull 2022:48(1):166-175.
44 Fiorito AM, Aleman A, Blasi G, Bourque J, Cao H, Chan RC, Chowdury A, Conrod P, Diwadkar VA, Goghari VM, Guinjoan S, Gur RE, Gur RC, Kwon JS, Lieslehto J, Lukow PB, Meyer-Lindenberg A, Modinos G, Quarto T, Spilka MJ, et al. Are Brain Responses to Emotion a Reliable Endophenotype of Schizophrenia? An Image-Based Functional Magnetic Resonance Imaging Meta-analysis. Biol Psychiatry 2023:93(2):167-177.
45 Husso M, Sipola P, Kuittinen T, Manninen H, Vainio P, Hartikainen J, Saarakkala S, Töyräs J, Kuikka J. Assessment of myocardial perfusion with MRI using a modified dual bolus method. Physiol Meas 2014:35(4):533-547.
46 Olubamwo O, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Association between route of illicit drug administration and hospitalizations for infective endocarditis. SAGE Open Med 2017:5:2050312117740987.
47 Onyeka IN, Basnet S, Beynon CM, Tiihonen J, Tiihonen J, Föhr J, Kauhanen J. Association between routes of drug administration and all-cause mortality among drug users. J Subst Use 2016:21(6):559-565.
48 Tiihonen J, Halonen P, Tiihonen L, Kautiainen H, Storvik M, Callaway J. The association of ambient temperature and violent crime. Sci Rep 2017:7(1):6543.
49 Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. JAMA Psychiatry 2019:76(5):499-507.
50 Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, Tiihonen J. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. JAMA Psychiatry 2023:80(1):31-39.
51 Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Association of pharmacological treatments and real-world outcomes in borderline personality disorder. Acta Psychiatr Scand 2023:147(6):603-613.
52 Tarvainen A, Hartikainen S, Taipale H, Tanskanen A, Koponen M, Tolppanen AM. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease. Int J Geriatr Psychiatry 2021:36(7):1075-1084.
53 Mittendorfer-Rutz E, Härkänen T, Tiihonen J, Haukka J. Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression. PLoS ONE 2014:9(6):e99869.
54 Lundberg J, Cars T, Lööv S, Söderling J, Sundström J, Tiihonen J, Leval A, Gannedahl A, Björkholm C, Själin M, Hellner C. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study. JAMA Psychiatry 2023:80(2):167-175.
55 Lähteenvuo M, Luykx JJ, Taipale H, Mittendorfer-Rutz E, Tanskanen A, Batalla A, Tiihonen J. Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts. Br J Psychiatry 2022:221(6):758-765.
56 Herttua K, Crawford M, Paljarvi T, Fazel S. Associations between antipsychotics and risk of violent crimes and suicidal behaviour in personality disorder. Evid Based Ment Health 2022:25(e1):e58-e64.
57 Bendre M, Comasco E, Checknita D, Tiihonen J, Hodgins S, Nilsson KW. Associations between MAOA-uVNTR genotype, maltreatment, MAOA methylation, and alcohol consumption in young adult males. Alcohol Clin Exp Res 2018:42(3):508-519.
58 Checknita D, Tiihonen J, Hodgins S, Nilsson KW. Associations of age, sex, sexual abuse, and genotype with monoamine oxidase a gene methylation. J Neural Transm 2021:128(11):1721-1739.
59 Checknita D, Ekström TJ, Comasco E, Nilsson KW, Tiihonen J, Hodgins S. Associations of monoamine oxidase A gene first exon methylation with sexual abuse and current depression in women. J Neural Transm 2018:125(7):1053-1064.
60 Lindner P, Flodin P, Budhiraja M, Savic I, Jokinen J, Tiihonen J, Hodgins S. Associations of Psychopathic Traits With Local and Global Brain Network Topology in Young Adult Women. Biol Psychiatry Cogn Neurosci Neuroimaging 2018:3(12):1003-1012.
61 Lampela P, Tolppanen A, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease. J Alzheimers Dis 2020:73(3):1243-1251.
62 Boccardi M, Bocchetta M, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J, Frisoni GB. Atypical nucleus accumbens morphology in psychopathy: Another limbic piece in the puzzle. Int J Law Psychiatry 2013:36:157-167.
63 Vallius S, Taipale H, Koponen M, Tolppanen A, Tanskanen A, Hartikainen S, Tiihonen M. Automated multi-dose dispensing in persons with and without Alzheimer's disease-impacts on pharmacotherapy. Eur J Clin Pharmacol 2022:78(3):513-521.
64 Ojala KP, Tiihonen J, Repo-Tiihonen E, Tikkanen R, Virkkunen M. Basal insulin secretion, PCL-R and recidivism among impulsive violent alcoholic offenders. Psychiatry Res 2015:225(3):420-4.
65 Joensuu M, Ahola P, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Valkonen-Korhonen M, Vanninen R, Jääskeläinen T, Virtala E, Kuikka J, Tiihonen J, Lehtonen J. Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression. Psychiatry Clin Neurosci 2016:70(1):34-41.
66 Laukkanen E, Kuosmanen L, Louheranta O, Ryynänen O, Vehviläinen-Julkunen K. A Bayesian network model to identify the associations between the use of seclusion in psychiatric care and nursing managers' attitudes towards containment methods. J Psychiatr Mental Health Nurs 2021:28(5):815-828.
67 Taipale H, Särkilä H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Tuulio-henriksson A, Saastamoinen L, Hietala J:. Bentsodiatsepiinien käyttö pitkäaikaistuu yli kolmasosalla aloittajista. Duodecim 2021:137(1):103.
68 Kurko T, Saastamoinen L, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J. Bentsodiatsepiinien pitkäaikaiskäyttö on vähentynyt. Suomen Lääkärilehti 2018:73(20):1292-1299.
69 Nummenmaa L, Lukkarinen L, Sun L, Putkinen V, Seppälä K, Karjalainen T, Karlsson HK, Hudson M, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Lauerma H, Tiihonen J. Brain basis of psychopathy in criminal offenders and general population. Cereb Cortex 2021:31(9):4104-4114.
70 Noppari T, Sun L, Lukkarinen L, Putkinen V, Tani P, Lindberg N, Saure E, Lauerma H, Tiihonen J, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Salmi J, Nummenmaa L. Brain structural alterations in autism and criminal psychopathy. Neuroimage Clin 2022:35:103116.
71 Budhiraja M, Savic I, Lindner P, Jokinen J, Tiihonen J, Hodgins S. Brain structure abnormalities in young women who presented conduct disorder in childhood/adolescence. Cogn Affect Behav Neurosci 2017:17(4):869-885.
72 Mittendorfer-Rutz E, Rahman S, Tanskanen A, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Taipale H, Tiihonen J. Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls. Schizophr Bull 2019:45(4):794-803.
73 Solje E, Hartikainen P, Valori M, Vanninen R, Tiihonen J, Hakola P, Tienari PJ, Remes AM. The C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Neurobiol Aging 2014:35(7):1780e13-7.
74 Tolppanen A, Taipale H, Koponen M, Tiihonen J, Hartikainen S. Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease. BMC Geriatr 2020:20(1):441.
75 Paljärvi T, Herttua K, Taipale H, Lähteenvuo M, Tanskanen A, Fazel S, Tiihonen J. Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study. BMJ Ment Health 2023:26(1):e300700.
76 Ojansuu I, Ojansuu I, Putkonen H, Tiihonen J. Cause-specific mortality in Finnish forensic psychiatric patients. Nord J Psychiatry 2018:72(5):374-379.
77 Toivonen P, Könönen M, Niskanen E, Vaurio O, Repo-Tiihonen E, Seppänen A, Aronen HJ, Vanninen R, Tiihonen J, Laakso M. Cavum septum pellucidum and psychopathy. Br J Psychiatry 2013(203):152-153.
78 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Changes in patient safety culture: A patient safety intervention for Finnish forensic psychiatric hospital staff. J Nurs Manag 2019:27(4):848-857.
79 Kärkkäinen O, Kokla M, Lehtonen M, Auriola S, Martiskainen M, Tiihonen J, Karhunen PJ, Hanhineva K, Kok E. Changes in the metabolic profile of human male postmortem frontal cortex and cerebrospinal fluid samples associated with heavy alcohol use. Addiction Biology 2021:26(6):e13035.
80 Heikkinen N, Kärkkäinen O, Laukkanen E, Kekkonen V, Kaarre O, Kivimäki P, Könönen M, Velagapudi V, Nandania J, Lehto SM, Niskanen E, Vanninen R, Tolmunen T. Changes in the serum metabolite profile correlate with decreased brain gray matter volume in moderate-to-heavy drinking young adults. Alcohol 2019:75:89-97.
81 López-Rubio C, Koponen M, Lampela P, Taipale H, Tanskanen A, Bell JS, Tolppanen A, Hartikainen S. Changes in the use of diabetes drugs among community-dwelling people with Alzheimer's disease. BMC Geriatr 2021:21(1):701.
82 Basnet S, Onyeka IN, Tiihonen J, Föhr J, Kauhanen J. Characteristics of drug-abusing females with and without children seeking treatment in Helsinki, Finland. Scand J Public Health 2015:43(3):221-8.
83 Lundberg J, Cars T, Lööv S-Å, Söderling J, Tiihonen J, Leval A, Gannedahl A, Björkholm C, Själin M, Hellner C. Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm. Acta Psychiatr Scand 2022:146(1):51-63.
84 Sommer IE, Tiihonen J, van Mourik A, Tanskanen A, Taipale H. The clinical course of schizophrenia in women and men-a nation-wide cohort study. NPJ Schizophr 2020:6(1):12.
85 Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H. Clozapine and the risk of haematological malignancies - Authors' reply. Lancet Psychiatry 2022:9(7):539-540.
86 Leucht S, Tiihonen J. Clozapine, long-acting injectables (and polypharmacy?) superior in U.S. and international registries. Editorial. Am J Psychiatry 2021:178(10):888-889.
87 Tiihonen J, Leucht S. Clozapine resistance - Augmentation strategies. Eur Neuropsychopharmacology 2013:23:338.
88 Putkonen A, Kuivalainen S, Louheranta O, Repo-Tiihonen E, Ryynänen OP, Kautiainen H, Tiihonen J. Cluster-randomized controlled trial of reducing seclusion and restraint in secured care of men with schizophrenia. Psychiatr Serv 2013:64(9):850-855.
89 Laukkanen E. Coercive Measures in Finnish Psychiatric Inpatient Care: Special Emphasis on Psychiatric Nursing Managers' Attitudes. Doctoral dissertation. Kuopio: University of Eastern Finland, 2021. Publications of the University of Eastern Finland. Dissertations in Health Sciences 608. 110 p.
90 Onyeka IN, Beynon CM, Uosukainen H, Korhonen MJ, Ilomäki J, Bell JS, Paasolainen M, Tasa N, Tiihonen J, Kauhanen J. Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: The HUUTI study. BMC Public Health 2013:13:380.
91 Hallikainen I, Koivisto AM, Paajanen T, Hiltunen A, Karppi P, Vanhanen M, Välimäki T, Herukka S-K, Soininen H, Hänninen T. Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer's Disease: Kuopio ALSOVA Study. Dement Geriatr Cogn Disord 2012:2:209-218.
92 Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Aho-Mustonen K. Cognitive insight, clinical insight, and reasoning in schizophrenia: a pilot study in a forensic setting. J Forensic Psychol Pract 2016:16(4):253-267.
93 Lähteenvuo M, Ahola-Olli A, Suokas K, Holm M, Misiewicz Z, Jukuri T, Männynsalo T, Wegelius A, Haaki W, Kajanne R, Kyttälä A, Tuulio-Henriksson A, Lahdensuo K, Häkkinen K, Hietala J, Paunio T, Niemi-Pynttäri J, Kieseppä T, ..., Tiihonen J, et al. Cohort profile: SUPER-Finland - the Finnish study for hereditary mechanisms of psychotic disorders. BMJ Open 2023:13(4):e070710.
94 Tolppanen A, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 2016:6(7):e012100.
95 Solmi M, Estradé A, Thompson T, Agorastos A, Radua J, ..., Tiihonen J, et al. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic. J Affect Disord 2022:299:393-407.
96 Tiihonen J, Taipale H, Correll CU. Commentary on Robert Whitaker's viewpoint. Psychol Med 2020:50(16):2653-2654.
97 Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Comorbid opioid use is undertreated among forensic patients with schizophrenia. Subst Abuse Treat Prev Policy 2018:13(1):39.
98 Taipale H, Mehtälä J, Tanskanen A, Tiihonen J. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up. Schizophr Bull 2018:44(6):1381-1387.
99 Taipale H, Lähteenvuo M, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia. Schizophr Bull 2021:47(1):23-30.
100 Holm M, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder. Eur Neuropsychopharmacology 2022:61:36-42.
101 Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder. JAMA Netw Open 2023:6(6):e2317130.
102 Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013. Pharmacoepidemiol Drug Saf 2018:27(10):1112-1122.
103 Cullen AE, de Montgomery CJ, Norredam M, Bergström J, Krasnik A, Taipale H, Mittendorfer-Rutz E. Comparison of Hospitalization for Nonaffective Psychotic Disorders Among Refugee, Migrant, and Native-Born Adults in Sweden and Denmark. JAMA Netw Open 2023:6(10):e2336848.
104 Tolppanen A, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. BMC Geriatr 2016:16(1):204.
105 Moga DC, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Drugs Aging 2017:34(1):55-65.
106 van der Horst MZ, Meijer Y, de Boer N, Guloksuz S, Hasan A, Siskind D, Wagner E, ..., Hallikainen T, et al. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions. Psychiatry Res 2023:330:115539.
107 Torvinen-Kiiskinen S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Concomitant use of acetylcholine esterase inhibitors and urinary antispasmodics among Finnish community-dwelling persons with Alzheimer disease. J Clin Psychopharmacol 2014:34(6):722-7.
108 Karttunen N, Taipale H, Hamina A, Tanskanen A, Tiihonen J, Tolppanen A, Hartikainen S. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland. Int J Geriatr Psychiatry 2019:34(2):280-288.
109 Ahola P, Härkänen T, Lehtonen J, Lindfors O, Knekt P, Joensuu M, Saarinen P, Tolmunen T, Virtala E, Tiihonen J, Valkonen-Korhonen M. Concordance and discordance in how patients and therapists experience the psychotherapy process in the treatment of depression. Psychiatr Fenn 2020:51:122-141.
110 Lindner P, Savic I, Sitnikov R, Budhiraja M, Liu Y, Jokinen J, Tiihonen J, Hodgins S. Conduct disorder in females is associated with reduced corpus callosum structural integrity independent of comorbid disorders and exposure to maltreatment. Transl Psychiatry 2016:6:e714.
111 Lehti V, Taipale H, Gissler M, Tanskanen A, Elonheimo M, Tiihonen J, Suvisaari J. Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study. Psychol Med 2023:53(3):833-843.
112 Koskuvi M, Lehtonen S, Trontti K, Keuters M, Wu Y, Koivisto H, Ludwig A, Plotnikova L, Virtanen PL, Räsänen N, Kaipainen S, Hyötyläinen I, Dhungana H, Giniatullina R, Ojansuu I, Vaurio O, ..., Lähteenvuo M, ..., Tiihonen J, et al. Contribution of astrocytes to familial risk and clinical manifestation of schizophrenia. Glia 2022:70(4):650-660.
113 Tiihonen J, Koskuvi M, Lähteenvuo M, Virtanen PL, Ojansuu I, Vaurio O, Gao Y, Hyötyläinen I, Puttonen KA, Repo-Tiihonen E, Paunio T, Rautiainen M, Tyni S, Koistinaho J, Lehtonen S. Correction: Neurobiological roots of psychopathy. Mol Psychiatry 2020:25(12):3455-3456.
114 Hodgins S, Eronen M, Freese R, Hart S, Mueller-Isberner R, Ross D, Webster C, Tiihonen J. Correspondence regarding De Girolamo et al., 2021 'A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum disorders: the EU-VIORMED project'. Psychol Med 2023:53(8):3764-3765.
115 Budhiraja M, Pereira JB, Lindner P, Westman E, Jokinen J, Savic I, Tiihonen J, Hodgins S. Cortical structure abnormalities in females with conduct disorder prior to age 15. Psychiatry Res Neuroimaging 2019:289:37-44.
116 Juntunen A, Määttä S, Könönen M, Kallioniemi E, Niskanen E, Kaarre O, Kivimäki P, Vanninen R, Tolmunen T, Ferreri F, Kekkonen V. Cortical thickness is inversely associated with transcranial magnetic stimulation-evoked N45 potential among young adults whose heavy drinking began in adolescence. Alcohol Clin Exp Res (Hoboken) 2023:47(7):1341-1351.
117 Lähteenvuo M, Taipale H, Tanskanen A, Rannanpää S, Tiihonen J. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study. J Affect Disord 2022:308:236-242.
118 Rahkonen A, Taipale H, Koponen M, Hartikainen S, Tolppanen A, Tanskanen A, Tiihonen M. The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer's Disease: A Nationwide Case-Control Study. J Alzheimers Dis 2023:91(4):1283-1290.
119 Laukkanen V, Storvik M, Häkkinen M, Akamine Y, Tupala E, Virkkunen M, Tiihonen J. Decreased GABA(A) benzodiazepine binding site densities in postmortem brains of Cloninger type 1 and 2 alcoholics. Alcohol 2013:47:103-108.
120 Laukkanen V, Laukkanen V, Kärkkäinen O, Kautiainen H, Tiihonen J, Storvik M. Decreased [³H]naloxone Binding in the Dentate Gyrus of Cloninger Type 1 Anxiety-Prone Alcoholics: A Postmortem Whole-Hemisphere Autoradiography Study. Alcohol Clin Exp Res 2015:39(8):1352-9.
121 Kuivalainen S, Vehviläinen-Julkunen K, Louheranta O, Putkonen A, Repo-Tiihonen E, Tiihonen J. De-escalation techniques used, and reasons for seclusion and restraint, in a forensic psychiatric hospital. Int J Ment Health Nurs 2017:26(5):513-524.
122 Suokas JT, Suvisaari JM, Haukka J, Korhonen P, Tiihonen J. Description of long-term polypharmacy among schizophrenia outpatiens. Soc Psychiatry Psychiatr Epidemiol 2013:48:631-638.
123 Braithwaite B, Paananen J, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory. Int J Med Inf 2020:141:104142.
124 Olubamwo OO, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Determinants of hospitalizations for pneumonia among Finnish drug users. SAGE Open Med 2018:6:2050312118784311.
125 Aregbesola A, Onyeka IN, Olubamwo O, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Diabetes hospitalizations and deaths in a cohort of treatment-seeking illicit drug users. SAGE Open Med 2018:6:2050312118768164.
126 Laakso MP, Jukarainen NM, Vepsäläinen J. Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid. J Neurol Neurosurg Psychiatry 2015:86(12):1286-90.
127 Hamina A, Taipale H, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease. Eur J Pain 2017:21(4):658-667.
128 Ahti J, Kieseppä T, Suvisaari J, Suokas K, Holm M, Wegelius A, Ahola-Olli A, Häkkinen K, Kampman O, Lähteenvuo M, Paunio T, Tiihonen J, Tuulio-Henriksson A, Isometsä E. Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study. Schizophr Res 2022:244:10-17.
129 Hakala A, Tolppanen A, Koponen M, Taipale H, Tanskanen A, Hartikainen S, Tiihonen M. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease? J Am Med Dir Assoc 2021:22(7):1543-1547.e3.
130 Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. Drug exposure in register-based research-An expert-opinion based evaluation of methods. PLoS ONE 2017:12(9):e0184070.
131 Lintunen J. Drug Repurposing in Severe Mental Disorders. Findings from Nationwide Register-Based Studies. Doctoral dissertation. Kuopio: University of Eastern Finland, 2022. Publications of the University of Eastern Finland. Dissertations in Health Sciences 695. 138 p.
132 Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Drug use in persons with and without Alzheimer's disease aged 90 years or more. Age Ageing 2016:45(6):900-904.
133 Tanskanen A. Drug Use Modelling Method PRE2DUP. From Prescriptions to Drug Use Periods. Doctoral dissertation. Kuopio: University of Eastern Finland, 2019. Publications of the University of Eastern Finland. Dissertations in Health Sciences 514. 59 p.
134 Kettunen R, Taipale H, Tolppanen A, Tanskanen A, Tiihonen J, Hartikainen S, Koponen M. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease. Eur J Clin Pharmacol 2019:75(3):417-425.
135 Saarinen A, Keltikangas-Järvinen L, Jääskeläinen E, Huhtaniska S, Pudas J, Tovar-Perdomo S, Penttilä M, Miettunen J, Lieslehto J. Early Adversity and Emotion Processing From Faces: A Meta-analysis on Behavioral and Neurophysiological Responses. Biol Psychiatry Cogn Neurosci Neuroimaging 2021:6(7):692-705.
136 Torvinen-Kiiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Editorial: let's take a break from studying the PPI-fracture association-Authors' reply. Editorial. Aliment Pharmacol Ther 2018:47(11):1544-1545.
137 Solmi M, Taipale H, Holm M, Tanskanen A, Mittendorfer-Rutz E, Correll CU, Tiihonen J. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis. Am J Psychiatry 2022:179(12):938-946.
138 Lähteenvuo M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients. Schizophr Res 2021:228:367-372.
139 Tikkanen R, Saukkonen T, Fex M, Bennet H, Rautiainen MR, Paunio T, Koskinen M, Panarsky R, Bevilacqua L, Sjöberg RL, Tiihonen J, Virkkunen M. The effects of a HTR2B stop codon and testosterone on energy metabolism and beta cell function among antisocial Finnish males. J Psychiatric Res 2016:81:79-86.
140 Shen Q, Heikkinen N, Kärkkäinen O, Gröhn H, Könönen M, Liu Y, Kaarre O, Zhang Z, Tan C, Tolmunen T, Vanninen R. Effects of long-term adolescent alcohol consumption on white matter integrity and their correlations with metabolic alterations. Psychiatry Res Neuroimaging 2019:294:111003.
141 Ahola P, Joensuu M, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Valkonen-Korhonen M, Jääskeläinen T, Virtala E, Tiihonen J, Lehtonen J. Effects of Scheduled Waiting for Psychotherapy in Patients With Major Depression. J Nerv Ment Dis 2017:205(8):611-617.
142 Taipale M, Tiihonen J, Korhonen J, Popovic D, Vaurio O, Lähteenvuo M, Lieslehto J. Effects of Substance Use and Antisocial Personality on Neuroimaging-Based Machine Learning Prediction of Schizophrenia. Schizophr Bull 2023:49(6):1568-1578.
143 Holopainen R, Tiihonen J, Lähteenvuo M. Efficacy of immersive extended reality (XR) interventions on different symptom domains of schizophrenia spectrum disorders. A systematic review. Front Psychiatry 2023:14:1208287.
144 Stenius J, Heinonen E, Lindfors J, Holma J, Knekt P. Ego Impairment Index (EII-2) as a predictor of outcome in short- and long-term psychotherapy during a 5-year follow-up. J Clin Psychol 2022:78(9):1739-1751.
145 Holm M, Taipale H, Tanskanen A, Tiihonen J, Mitterdorfer-Rutz E. Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers. Acta Physiol Scand 2021:143(1):61-71.
146 Kärkkäinen OK, Lehtonen M, Laukkanen V, Tupala E, Hyytiä P, Kautiainen H, Tiihonen J, Callaway JC, Storvik M. Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics. Alcohol 2013:47:399-403.
147 Tiihonen E. Epäsosiaalinen persoonallisuushäiriö. Lääkärin käsikirja - viimeisin muutos 12.4.2013.
148 Repo-Tiihonen E, Hallikainen T. Epäsosiaalinen persoonallisuushäiriö. Duodecim 2016:132(2):130-6.
149 Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yagcioglu AE, Tiihonen J, Kennedy JL, Meltzer HY. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis. Mol Psychiatry 2014:19(4):403-5.
150 Weizmann-Henelius G, Putkonen H, Rissanen T, Eronen M, Webster CD. Exploring a new structured professional judgment measure (impulsivity measure related to violence) after an average follow-up of 10 years: A study of Finnish offenders. Crim Behav Ment Health 2019:29(1):57-68.
151 Pauli M, Ölund Alonso H, Liljeberg J, Gustavsson P, Tiihonen J, Howner K. Exploring the relation between high-activity COMT Val158Met genotype and psychopathy in male offenders. J Forensic Psychiatry Psychol 2022:33(1):172-177.
152 Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction 2013:108(7):1279-1286.
153 Kekkonen V, Kraav S-L, Hintikka J, Kivimäki P, Kaarre O, Tolmunen T. Externally oriented thinking style increases primary health care use in adolescence. Eur J Public Health 2023:33(3):418-423.
154 Askola R, Louheranta O, Seppänen A. Factors Affecting Treatment Regress and Progress in Forensic Psychiatry: A Thematic Analysis. Front Psychiatry 2022:13:884410.
155 Correll CU, Bitter I, Hoti F, Mehtälä J, Wooller A, Pungor K, Tiihonen J. Factors and their weight in reducing life expectancy in schizophrenia. Schizophr Res 2022:250:67-75.
156 Uosukainen H, Ilomäki J, Kauhanen J, Tacke U, Föhr J, Tiihonen J, Bell JS. Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland. J Subst Abuse Treat 2014:46(5):561-566.
157 Onyeka IN, Olubamwo O, Beynon CM, Ronkainen K, Förh J, Tiihonen J, Tuomola P, Tasa N, Kauhanen J. Factors Associated with Hospitalization for Blood-Borne Viral Infections Among Treatment-Seeking Illicit Drug Users. J Subst Abuse Treat 2015:53:71-77.
158 Vaurio O, Lähteenvuo M, Kautiainen H, Repo-Tiihonen E, Tiihonen J. Female Psychopathy and Mortality. Front Psychiatry 2022:13:831410.
159 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Firesetting and general criminal recidivism among a consecutive sample of Finnish pretrial male firesetters: A register-based follow-up study. Psychiatry Res 2018:259:377-384.
160 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Fire-setting performed in adolescence or early adulthood predicts schizophrenia: a register-based follow-up study of pre-trial offenders. Nord J Psychiatry 2017:71(2):96-101.
161 Askola R, Nikkonen M, Paavilainen E, Soininen P, Putkonen H, Louheranta O. Forensic Psychiatric Patients' Perspectives on Their Care: A Narrative View. Perspect Psychiatr Care 2018:54(1):64-73.
162 Seppänen A, Joelsson P, Ahlgren-Rimpiläinen A, Repo-Tiihonen E. Forensic psychiatry in Finland: an overview of past, present and future. Int J Ment Health Syst 2020:14:29.
163 Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescription drug purchases to drug use periods - a second generation method (PRE2DUP). BMC Med Inform Decis Mak 2015:15:21.
164 Tanskanen A1, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescriptions to drug use periods - things to notice. BMC Res Notes 2014:7:796.
165 Häkkinen K, Kiander W, Kidron H, Lähteenvuo M, Urpa L, Lintunen J, Vellonen K, Auriola S, Holm M, Lahdensuo K, Kampman O, Isometsä E, Kieseppä T, Lönnqvist J, Suvisaari J, Hietala J, Tiihonen J, Palotie A, Ahola-Olli AV, Niemi M. Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Mol Pharm 2023:20(3):1500-1508.
166 Ojansuu I, Latvala A, Kautiainen H, Forsman J, Tiihonen J, Lähteenvuo M. General and violent recidivism of former forensic psychiatric patients in Finland. Front Psychiatry 2023:14:1157171.
167 Tiihonen J, Rautiainen MR, Ollila HM, Repo-Tiihonen E, Virkkunen M, Palotie A, Pietiläinen O, Kristiansson K, Joukamaa M, Lauerma H, Saarela J, Tyni S, Vartiainen H, Paananen J, Goldman D, Paunio T. Genetic background of extreme violent behavior. Mol Psychiatry 2015:20(6):786-92.
168 Okhuijsen-Pfeifer C, van der Horst MZ, Bousman CA, Lin B, van Eijk KR, Ripke S, Ayhan Y, Babaoglu MO, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, ..., Hallikainen T, Lähteenvuo M, Repo-Tiihonen E, Tuppurainen H, Tiihonen J, et al. Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders. Transl Psychiatry 2022:12(1):145.
169 Tielbeek JJ, Johansson A, Polderman TJ, Rautiainen MR, Jansen P, Taylor M, Tong X, Lu Q, Burt AS, ..., Paunio T, Tiihonen J, ..., Posthuma D. Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior. JAMA Psychiatry 2017:74(12):1242-1250.
170 Rautiainen MR, Paunio T, Repo-Tiihonen E, Virkkunen M, Ollila HM, Sulkava S, Jolanki O, Palotie A, Tiihonen J. Genome-wide association study of antisocial personality disorder. Transl Psychiatry 2016:6(9):e883.
171 Sabe M, Pillinger T, Kaiser S, Chen C, Taipale H, Tanskanen A, Tiihonen J, Leucht S, Correll CU, Solmi M. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev 2022:136:104608.
172 Tolppanen A-M, Taipale H, Hartikainen S. Head or brain injuries and Alzheimer's disease: A nested case-control register study. Alzheimers Dement 2017:13(12):1371-1379.
173 Taipale H, Rahman S, Tanskanen A, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tiihonen J, Mittendorfer-Rutz E. Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring. Sci Rep 2020:10(1):1219.
174 Di Thiene D, Rahman S, Helgesson M, Wang M, Alexanderson K, Tiihonen J, La Torre G, Mittendorfer-Rutz E. Healthcare use among immigrants and natives in Sweden on disability pension, before and after changes of regulations. Eur J Public Health 2018:28(3):445-451.
175 Taipale H, Lähteenvuo M, Tanskanen A, Huoponen S, Rannanpää S, Tiihonen J. Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study. BMC Psychiatry 2022:22(1):484.
176 Kekkonen V, Kallioniemi E, Kaarre O, Könönen M, Kivimäki P, Gröhn H, Tolmunen T, Vanninen R. Heavy drinking from adolescence to young adulthood is associated with an altered cerebellum. Alcohol 2021:92:35-40.
177 Louheranta O, Lähteenvuo M, Lähteenvuo M, Kangasniemi M. Henkinen ja hengellinen tuki terveydenhuollossa kenen vastuulla? . Sosiaalilääketieteellinen aikakauslehti 2016:53(4):234-241.
178 Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. Eur Neuropsychopharmacology 2014:24(11):1729-37.
179 Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clin Epidemiol 2021:13:295-307.
180 Konte B, Walters JT, Rujescu D, Legge SE, Pardiñas AF, Cohen D, Pirmohamed M, Tiihonen J, Hartmann AM, Bogers JP, van der Weide J, van der Weide K, Putkonen A, Repo-Tiihonen E, Hallikainen T, Silva E, Ingimarsson O, Sigurdsson E, et al. HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry. Transl Psychiatry 2021:11(1):214.
181 Taipale H, Purhonen M, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort. Scand J Public Health 2016:44(2):150-8.
182 Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S. Hospitalization after oral antibiotic initiation in Finnish community dwellers with and without Alzheimer's disease: retrospective register-based cohort study. J Alzheimers Dis 2018:64(2):437-445.
183 Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study. J Alzheimers Dis 2018:64(2):437-445.
184 Onyeka IN, Beynon CM, Ronkainen K, Tiihonen J, Föhr J, Kuikanmäki O, Paasolainen M, Kauhanen J. Hospitalization in a cohort seeking treatment for illicit drug use in Finland. J Subst Abuse Treat 2015:53:64-70.
185 Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen A-M. Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: A nationwide nested case-control study. Eur Psychiatry: J Assoc Eur Psychiatr 2017:43:92-98.
186 Hamina A, Taipale H, Karttunen N, Tanskanen A, Tiihonen J, Tolppanen A, Hartikainen S. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease. J Alzheimers Dis 2019:69(3):807-816.
187 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N, Tiihonen J. Hospital-treated suicide attempts among Finnish fire setters: a follow-up study. Crim Behav Ment Health 2016:26(5):395-402.
188 Kauhanen J, Tiihonen J. Huumeiden terveysriskit Suomessa - voiko niitä hallita? HUUTI-tutkimuksen antia. Duodecim 2017:133(1):34-42.
189 Hamina A, Lavikainen P, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, Taipale H. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease. Int Psychogeriatr 2018:30(7):947-956.
190 Häkkinen K, Kiiski JI, Lähteenvuo M, Jukuri T, Suokas K, Niemi-Pynttäri J, Kieseppä T, Männynsalo T, Wegelius A, Haaki W, Lahdensuo K, Kajanne R, Kaunisto MA, Tuulio-Henriksson A, Kampman O, Hietala J, Veijola J, ..., Tiihonen J, et al. Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder. Pharmacogenomics J 2022:22(3):166-172.
191 Tikkanen R, Tiihonen J, Rautiainen MR, Paunio T, Bevilacqua L, Panarsky R, Goldman D, Virkkunen M. Impulsive alcohol-related risk-behavior and emotional dysregulation among individuals with a serotonin 2B receptor stop codon. Transl Psychiatry 2015:5:e681.
192 Luykx JJ, Stam N, Tanskanen A, Tiihonen J, Taipale H. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine. Br J Psychiatry 2020:217(3):498-505.
193 Tiihonen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease. J Alzheimers Dis 2016:52(1):127-32.
194 Sarycheva T, Taipale H, Lavikainen P, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A-M. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease. J Alzheimers Dis 2018:66(1):387-395.
195 Taipale H, Särkilä H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Tuulio-Henriksson A, Saastamoinen L, Hietala J. Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland. JAMA Netw Open 2020:3(10):e2019029.
196 Hentilä E, Tiihonen M, Taipale H, Hartikainen S, Tolppanen A. Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study. BMC Geriatr 2021:21(1):202.
197 Puranen A, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up. Int J Geriatr Psychiatry 2017:32(1):94-101.
198 Koponen M, Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Johnell K, Fastbom J, Ahonen R, Hartikainen S. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons. Br J Psychiatry 2015:207(5):444-9.
199 Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. J Alzheimers Dis 2015:49(3):809-18.
200 Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, Tiihonen J, Hartikainen S. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. J Alzheimers Dis 2016:49(3):809-18.
201 Ilmaniemi S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. Incidence of head injury and traumatic brain injury among people with Alzheimer's disease. J Epidemiol Community Health 2019:73(5):451-454.
202 Tanskanen A, Taipale H, Cannon M, Cotter D, Tiihonen J. Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases. Acta Psychiatr Scand 2021:143(6):487-494.
203 Taipale H, Hamina A, Karttunen N, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study. Pain 2019:160(2):417-423.
204 Hyttinen V, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Valtonen H. Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease. Ann Pharmacother 2017:51(9):725-734.
205 Laukkanen V, Kärkkäinen O, Kupila J, Kautiainen H, Tiihonen J, Storvik M. Increased metabotropic glutamate 2/3 receptor binding in the perigenual anterior cingulate cortex of cloninger type 2 alcoholics: a whole-hemisphere autoradiography study. Alcohol Alcohol 2015:50(1):62-67.
206 Kärkkäinen O, Häkkinen MR, Auriola S, Kautiainen H, Tiihonen J, Storvik M. Increased steroid hormone dehydroepiandrosterone and pregnenolone levels in post-mortem brain samples of alcoholics. Alcohol 2016:52:63-70.
207 Laukkanen V, Kärkkäinen O, Kautiainen H, Tiihonen J, Storvik M. Increased [³H]quisqualic acid binding density in the dorsal striatum and anterior insula of alcoholics: A post-mortem whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2019:287:63-69.
208 Tikkanen R, Saukkonen T, Fex M, Bennet H, Rautiainen MR, Paunio T, Koskinen M, Panarsky R, Bevilacqua L, Sjöberg RL, Tiihonen J, Tiihonen J, Virkkunen M. Influence of a HTR2B stop codon on glucagon homeostasis and glucose excursion in non-diabetic men. Exp Clin Endocrinol Diabetes 2016:124(9):529-534.
209 Kauppila E, Vanninen E, Kaurijoki S, Karhunen L, Pietiläinen KH, Rissanen A, Tiihonen J, Pesonen U, Kaprio J. Influence of serotonin transporter gene polymorphism (5-HTTLPR Polymorphism) on the relation between brain 5-HT transporter binding and heart rate correcrted cardiac repolarization interval. PLoS ONE 2013:8(1):e50303.
210 Wingård L, Taipale H, Reutfors J, Westerlund A, Bodén R, Tiihonen J, Tanskanen A, Andersen M. Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder. Bipolar Disord 2018:20(7):634-646.
211 Taipale H, Niederkrotenthaler T, Helgesson M, Sijbrandij M, Berg L, Tanskanen A, Mittendorfer-Rutz E. Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study . Soc Psychiatry Psychiatr Epidemiol 2021:56(3):463-474.
212 Luykx JJ, Gonzalez-Diaz JM, Guu T, van der Horst MZ, van Dellen E, Boks MP, Guloksuz S, DeLisi LE, Sommer IE, Cummins R, Shiers D, Lee J, Every-Palmer S, Mhalla A, Chadly Z, Chan SK, Cotes RO, Takahashi S, Benros ME, Wagner E, ..., Tiihonen J, et al. An international research agenda for clozapine-resistant schizophrenia. Lancet Psychiatry 2023:10(8):644-652.
213 Räsänen N, Tiihonen J, Koskuvi M, Lehtonen S, Koistinaho J. The iPSC perspective on schizophrenia. Trends Neurosci 2022:45(1):8-26.
214 Taipale H, Hamina A, Lampela P, Tanskanen A, Tiihonen J, Karttunen N, Tolppanen A-M, Hartikainen S. Is Alzheimer's Disease Associated with Previous Opioid Use? Pain Med 2018:19(11):2115-2121.
215 Paljarvi T, McPherson T, Luciano S, Herttua K, Fazel S. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data. Br J Dermatol 2022:187(1):64-72.
216 Rytkönen M. Kehityskulkuja ja väliintuloja. Ekologinen näkökulma vakavan väkivallanteon tehneiden nuorten sosioemotionaalisen terveyden kehitykseen. Väitöskirja. Kuopio: 2013. Publications of the University of Eastern Finland. Dissertations in Health Sciences 177. 137 s.
217 Keränen T, Kaski M, Scheinin M, Rinne J, Repo-Tiihonen E, Vartiainen H, Halila R, Heinonen S, Halkoaho A, Bendel S, Uusaro A, Turgut T, Roine RO, Launis V, Pasternack A. Kliininen tutkimus erityisryhmille. Kirjassa: Tapani Keränen, Amos Pasternack., toim. Kliinisen tutkimuksen etiikka : opas tutkijoille ja eettisille toimikunnille., s. 62-83. Helsinki: Duodecim, 2015.
218 Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H. Klotsapiinihoitoon liittyy suurentunut hematologisen syövän riski. Duodecim 2022:138(9):843.
219 Purhonen M, Koponen H, Tiihonen J, Tanskanen A. Kun psyykenlääke vain katoaa. Pääkirjoitus. Duodecim 2014:130:438-439.
220 Helgesson M, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E. Labour market marginalisation in young adults diagnosed with attention-deficit hyperactivity disorder (ADHD): a population-based longitudinal cohort study in Sweden. Psychol Med 2023:53(4):1224-1232.
221 Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer's Disease: A Cohort Study in Finland. J Gerontol A Biol Sci Med Sci 2020:75(11):2184-2192.
222 Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review. Eur Neuropsychopharmacology 2019:29(4):457-470.
223 Rubio JM, Taipale H, Tanskanen A, Correll CU, Kane JM, Tiihonen J. Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study. Schizophr Bull 2021:47(6):1611-1620.
224 Lintunen J, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J, Lähteenvuo M. Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder. Schizophr Bull 2021:47(4):1099-1107.
225 Taipale H, Rysä J, Hukkanen J, Koponen M, Tanskanen A, Tiihonen J, Kröger H, Hartikainen S, Tolppanen A. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study. Osteoporos Int 2019:30(7):1481-1489.
226 Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland. Lancet Psychiatry 2022:9(5):353-362.
227 Koponen M, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Ahonen R, Hartikainen S. Long-term use of antipsychotics among community-dwelling persons with Alzheimer?s disease: A nationwide register-based study. Eur Neuropsychopharmacology 2015:25(10):1706-13.
228 Taipale H, Koponen M, Tanskanen A, Tolppanen A, Tiihonen J, Hartikainen S. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease. Int Clin Psychopharmacol 2015:30(4):202-8.
229 Kurko TA, Saastamoinen LK, Tähkäpää S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J. Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry: J Assoc Eur Psychiatr 2015:30(8):1037-47.
230 Hamina A, Taipale H, Tanskanen A, Tolppanen A, Karttunen N, Pylkkänen L, Tiihonen J, Hartikainen S. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study. Pain 2017:158(2):252-260.
231 Juntunen H, Taipale H, Tanskanen A, Tolppanen A, Tiihonen J, Hartikainen S, Tiihonen M. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease. Eur J Clin Pharmacol 2017:73(9):1149-1158.
232 Kärkkäinen O, Laukkanen V, Haukijärvi T, Kautiainen H, Tiihonen J, Storvik M. Lower [3H]Citalopram binding in brain areas related to social cognition in alcoholics. Alcohol Alcohol 2015:50(1):46-50.
233 Tiihonen J. Lääkehoito voi vähentää psyykkisiin sairauksiin liittyvää ennenaikaista kuolleisuutta. Suomen Lääkärilehti 2022:77(47-48):1999.
234 Lieslehto J, Rantanen N, Oksanen LA, Oksanen SA, Kivimäki A, Paju S, Pietiäinen M, Lahdentausta L, Pussinen P, Anttila V, Lehtonen L, Lallukka T, Geneid A, Sanmark E. A machine learning approach to predict resilience and sickness absence in the healthcare workforce during the COVID-19 pandemic. Sci Rep 2022:12(1):8055.
235 Maron E, Baldwin DS, Balotsev R, ..., Lähteenvuo M, ..., Tiihonen J, et al. Manifesto for an international digital mental health network. Digital Psychiatry 2019:2(1):14-24.
236 Isohanni M, Jääskeläinen E, Miller BJ, Hulkko A, Tiihonen J, Möller H-J, Hartikainen S, Huhtaniska S, Lieslehto J. Medication management of antipsychotic treatment in schizophrenia - a narrative review. Hum Psychopharmacol Clin Exp 2021:36:e2765.
237 Hamina A, Tanskanen A, Tiihonen J, Taipale H. Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia: A Nationwide Analysis. Med Care 2020:58(9):763-769.
238 Rantanen N, Lieslehto J, Oksanen L-M, Oksanen SA, Anttila V-J, Lehtonen L, Geneid A, Sanmark E. Mental well-being of healthcare workers in 2 hospital districts during the first wave of the COVID-19 pandemic in Finland: a cross-sectional study. Int J Occup Environ Health 2022:35(6):707-718.
239 Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J. Metacognitive group training for forensic and dangerous non-forensic patients with schizophrenia: A randomised controlled feasibility trial. Crim Behav Ment Health 2014:24(5):345-57.
240 Sluggett JK, Koponen M, Bell JS, Taipale H, Tanskanen A, Tiihonen J, Uusitupa M, Tolppanen A, Hartikainen S. Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study. J Clin Endocrinol Metab 2020:105(4):dgz234.
241 Kupila J, Kärkkäinen O, Laukkanen V, Tupala E, Tiihonen J, Storvik M. mGluR1/5 receptor densities in the brains of alcoholic subjects: A whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2013:212:245-250.
242 Rauhala A, Kinnunen M, Kuosmanen A, Liukka M, Olin K, Sahlström M, Roine RP. Mitä vapaaehtoiset vaaratapahtumailmoitukset kertovat? Suomen Lääkärilehti 2018:73(46):2716-2720.
243 Tiihonen J, Koskuvi M, Lähteenvuo M, Trontti K, Ojansuu I, Vaurio O, Cannon TD, Lönnqvist J, Therman S, Suvisaari J, Cheng L, Tanskanen A, Taipale H, Lehtonen S, Koistinaho J. Molecular signaling pathways underlying schizophrenia. Schizophr Res 2021:232:33-41.
244 Checknita D, Bendre M, Ekström TJ, Comasco E, Tiihonen J, Hodgins S, Nilsson KW. Monoamine oxidase A genotype and methylation moderate the association of maltreatment and aggressive behaviour. Behav Brain Res 2020:382:112476.
245 Tolppanen A, Ahonen R, Koponen M, Lavikainen P, Purhonen M, Taipale H, Tanskanen A, Tiihonen J, Tiihonen M, Hartikainen S. Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study. J Prev Med Public Health 2016:49(2):134-8.
246 Lähteenvuo M, Batalla A, Luykx JJ, Mittendorfer-Rutz E, Tanskanen A, Tiihonen J, Taipale H. Morbidity and mortality in schizophrenia with comorbid substance use disorders. Acta Psychiatr Scand 2021:144(1):42-49.
247 Uosukainen H, Kauhanen J, Bell JS, Ronkainen K, Tiihonen J, Föhr J, Onyeka IN, Korhonen MJ. Mortality among clients seeking treatment for buprenorphine abuse in Finland. Drug Alcohol Depend 2013:133:391-397.
248 Ojansuu I, Putkonen H, Tiihonen J. Mortality among forensic psychiatric patients in Finland. Nord J Psychiatry 2015:69(1):25-7.
249 Tiihonen J, Mittendorfer-Rutz E, Torniainen M, Alexanderson K, Tanskanen A. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study. Am J Psychiatry 2016:173(6):600-6.
250 Correll CU, Solmi M, Croatto G, Kolton Schneider L, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 2022:21(2):248-271.
251 Paljärvi T, Tiihonen J, Lähteenvuo M, Tanskanen A, Fazel S, Taipale H. Mortality in psychotic depression: 18-year follow-up study. Br J Psychiatry 2023:222(1):37-43.
252 Tanskanen A, Tiihonen J, Taipale H. Mortality in schizophrenia: 30-year nationwide follow-up study. Acta Psychiatr Scand 2018:138(6):492-499.
253 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Mortality of firesetters: a follow-up study of Finnish male firesetters who underwent a pretrial forensic examination in 1973-1998. Psychiatry Res 2015:225(3):638-42.
254 Lebel JL, Duxbury JA, Putkonen A, Sprague T, Rae C, Sharpe J. Multinational experiences in reducing and preventing the use of restraint and seclusion. J Psychosoc Nurs Ment Health Serv 2014:52(11):22-9.
255 Sun L, Lukkarinen L, Putkinen V, Karlsson HK, Hirvonen J, Tiihonen J, Lauerma H, Scott S, Nummenmaa L. Mu-opioid receptor system modulates responses to vocal bonding and distress signals in humans. Philos Trans R Soc Lond B Biol Sci 2022:377(1863):20210181.
256 Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-rutz E, Lähteenvuo M, Tiihonen. Naltreksoni vähentää alkoholiongelmaisten sairaalahoitoja. Duodecim 2021:137(4):427.
257 Tiihonen J, Koskuvi M, Lähteenvuo M, Virtanen PL, Ojansuu I, Vaurio O, Gao Y, Hyötyläinen I, Puttonen KA, Repo-Tiihonen E, Paunio T, Rautiainen M, Tyni S, Koistinaho J, Lehtonen S. Neurobiological roots of psychopathy. Mol Psychiatry 2020:25(12):3432-3441.
258 Taipale H, Tolppanen A-M, Tiihonen M, Tanskanen A, Lic P, Tiihonen J, Hartikainen S. No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease. Am J Gastroenterol 2017:112(12):1802-1808.
259 Lintunen J, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder - A nationwide cohort study. J Affect Disord 2023:333:403-408.
260 Tenkanen H, Taskinen H, Kontio R, Repo-Tiihonen E, Tiihonen J, Kinnunen J. Nurses' Time Use in Forensic Psychiatry: Core Interventions Outlined in the Finnish Clinical Practice Guideline on Schizophrenia. J Forensic Nurs 2016:12(2):64-73.
261 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Nurses' views highlight a need for the systematic development of patient safety culture in forensic psychiatry nursing. J Patient Saf 2021:17(3):e228-e233.
262 Gémes K, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M. Occupational Branch and Labor Market Marginalization among Young Employees with Adult Onset of Attention Deficit Hyperactivity Disorder-A Population-Based Matched Cohort Study. Int J Environ Res Public Health 2022:19(12):7254.
263 Askola R, Louheranta O, Soininen P, Putkonen H, Åstedt-Kurki P, Paavilainen E. The Offense as Perceived by the Parents of Forensic Psychiatric Patients. Issues Ment Health Nurs 2017:38(9):705-711.
264 Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Henriksson M, Marttunen M, Partonen T, toim. Psykiatria, s. 697-715. Helsinki: Duodecim, 2014.
265 Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Marttunen M, Henriksson M, Partonen T, toim. Psykiatria, s. pkr02500. Duodecim, 2017.
266 Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Henriksson M, Marttunen M, Partonen T, toim. Psykiatria, s. 825-843. Helsinki: Duodecim, 2021.
267 Askola R, Nikkonen M, Vuorio O, Kylmä J. Oikeuspsykiatrisen potilaan toivottomuus ja toivo hoitosuhteessa. Pro terveys 2013(2):20-22.
268 Kivimies K, Repo-Tiihonen E, Kautiainen H, Maaranen P, Muhonen LH, Heikkinen M, Tiihonen J. Opioid abuse and hospitalization rates in patients with schizophrenia. Nord J Psychiatry 2016:70(2):128-32.
269 Lintula E, Tiihonen M, Taipale H, Tolppanen A, Tanskanen A, Tiihonen J, Hartikainen S, Hamina A. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease. Drugs Aging 2020:37(3):193-203.
270 Taipale H, Tanskanen A, Luykx JJ, Solmi M, Leucht S, Correll CU, Tiihonen J. Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia. Schizophr Bull 2022:48(4):774-784.
271 Makkonen P, Putkonen A, Korhonen J, Kuosmanen L, Kärkkäinen J. Pakon käytön vähentäminen ja turvallisuuden lisääminen psykiatrisessa hoidossa. Helsinki: Terveydenhuollon ja hyvinvoinnin laitos, 2016. THL Työpaperi 35. 44 s.
272 Kuosmanen L, Laukkanen E. Pakon käytön vähentäminen psykiatrisessa sairaalahoidossa. Duodecim 2019:135(10):925-931.
273 Cullen AE, Lindsäter E, Rahman S, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Helgesson M. Patient factors associated with receipt of psychological and pharmacological treatments among individuals with common mental disorders in a Swedish primary care setting. BJPsych Open 2023:9(2):e40.
274 Hipp K, Repo-Tiihonen E, Kuosmanen L, Katajisto J, Kangasniemi M. Patient participation in pro re nata medication in forensic psychiatric care: A nursing document analysis. J Psychiatr Mental Health Nurs 2021:28(4):611-621.
275 Hipp K, Kuosmanen L, Repo-Tiihonen E, Leinonen M, Louheranta O, Kangasniemi M. Patient participation in pro re nata medication in psychiatric inpatient settings: An integrative review. Int J Ment Health Nurs 2018:27(2):536-554.
276 Kuosmanen A. Patient Safety Culture in Forensic Psychiatric Hospital Care. Health Care Staff Perceptions'. Doctoral dissertation. Kuopio: University of Eastern Finland, 2021. Publications of the University of Eastern Finland. Dissertations in Health Sciences 648. 89 p.
277 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Patient safety culture in two Finnish state-run forensic psychiatric hospitals. J Forensic Nurs 2013:9(4):207-216.
278 Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Patients' Perceptions of Safety and Debriefing in Forensic Mental Health Care in Finland. J Forensic Nurs 2023:19(3):187-196.
279 Onyeka IN, Beynon CM, Hannila ML, Tiihonen J, Föhr J, Tuomola P, Kuikanmäki O, Tasa N, Paasolainen M, Kauhanen J. Patterns and 14-year trends in mortality among illicit drug users in Finland: the HUUTI study. Int J Drug Policy 2014:25(6):1047-53.
280 Popovic D, Wertz M, Geisler C, Kaufmann J, Lähteenvuo M, Lieslehto J, Witzel J, Bogerts B, Walter M, Falkai P, Koutsouleris N, Schiltz K. Patterns of risk-Using machine learning and structural neuroimaging to identify pedophilic offenders. Front Psychiatry 2023:14:1001085.
281 Taipale H, Niederkrotenthaler T, Tanskanen A, Cullen AE, Helgesson M, Berg L, Sijbrandij M, Klimek P, Mittendorfer-Rutz E. Persistence of antidepressant use among refugee youth with common mental disorder. J Affect Disord 2021:294:831-837.
282 Stam N, Taipale H, Tanskanen A, Isphording L, Okhuijsen-Pfeifer C, Schuiling-Veninga CC, Bos JH, Bijker BJ, Tiihonen J, Luykx JJ. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics. Clin Transl Sci 2020:13(6):1170-1177.
283 Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiatry 2017:4(7):547-553.
284 Solmi M, Estradé A , Thompson T, Agorastos A, Radua J, ..., Tiihonen J, et al. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A). . J Affect Disord 2022:299:367-376.
285 Kuokkanen R, Aho-Mustonen K, Muotka J, Lappalainen R, Tiihonen J. A Pilot Study of Group Administered Metacognitive Training (MCT) for Schizophrenia Patients in a High-Security Forensic Setting: Subjective Training Success and Health-Related Quality of Life. J Forensic Psychol Pract 2015:15(4):344-362.
286 Jokinen J, Königsson J, Moberg T, Jönsson EG, Tiihonen J, Nordström P, Oreland L, Åsberg M. Platelet monoamine oxidase activity and interpersonal violence in male suicide attempters. Psychiatry Res 2018:260:173-176.
287 Paloneva J, Autti T, Hakola P, Haltia MJ. Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews [Internet], https://www.ncbi.nlm.nih.gov/books/. Seattle (WA), USA: University of Washington, 2020.
288 Onyeka IN, Beynon CM, Vohlonen I, Tiihonen J, Föhr J, Ronkainen K, Kauhanen J. Potential Years of Life Lost Due to Premature Mortality Among Treatment-Seeking Illicit Drug Users in Finland. J Community Health 2015:40(6):1099-106.
289 Stenius J, Knekt P, Heinonen E, Holma J, Antikainen R, Lindfors O. Predicting the working alliance over the course of long-term psychodynamic psychotherapy with the Rorschach Ego Impairment Index, self-reported defense style, and performance-based intelligence: An evaluation of three methodological approaches. Psychoanal Psychol 2021:38(1):58-67.
290 Stenberg J-H, Terevnikov V, Joffe M, Tiihonen J, Chukhin E, Burkin M, Joffe G. Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia - A path model investigation. Neuropharmacology 2013:64:248-253.
291 Scheen L, Brandt L, Bodén R, Tiihonen J, Andersen M, Kieler H, Reutfors J. Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder - A nationwide cohort study. J Affect Disord 2015:172:204-210.
292 Kalamägi J, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease. Ann Med 2019:51(5):294-305.
293 Hamina A, Muller AE, Clausen T, Skurtveit S, Hesse M, Tjagvad C, Thylstrup B, Odsbu I, Zoega H, Jónsdóttir HL, Taipale H. Prescription opioids among older adults: ten years of data across five countries. BMC Geriatr 2022:22(1):429.
294 Vu M, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Kettunen R, Hartikainen S, Tolppanen A. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease. Int J Cardiol 2020:300:221-225.
295 Taipale H, Vuorikari H, Tanskanen A, Koponen M, Tiihonen J, Kettunen R, Hartikainen S. Prevalence of Drug Combination Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer’s Disease. Drugs Aging 2015:32(11):937-45.
296 Babar BA, Vu M, Koponen M, Taipale H, Tanskanen A, Kettunen R, Tiihonen M, Hartikainen S, Tolppanen A. Prevalence of oral anticoagulant use among people with and without Alzheimer's disease. BMC Geriatr 2022:22(1):464.
297 Asikainen J. Prevention Of Coercive Action In Forensic Psychiatric Inpatient Care - Use Of Debriefing. Doctoral dissertation. Kuopio: University of Eastern Finland, 2022. Publications of the University of Eastern Finland. Dissertations in Health Sciences 696. 111 p.
298 Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Previous forensic mental examination is a useful marker indicating effective violence relapse prevention among psychotic patients. Nord J Psychiatry 2014:68(5):311-5.
299 Lieslehto J, Tiihonen J, Lähteenvuo M, Tanskanen A, Taipale H. Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia. Schizophr Bull 2022:48(3):655-663.
300 Hipp K, Repo-Tiihonen E, Kuosmanen L, Katajisto J, Kangasniemi M. PRN medication events in a forensic psychiatric hospital: a document analysis of the prevalence and reasons. Int J Forensic Ment Health 2020:19(4):329-340.
301 Koskinen L1, Likitalo H, Aho J, Vuorio O, Meretoja R. The professional competence profile of Finnish nurses practising in a forensic setting. J Psychiatr Mental Health Nurs 2014:21(4):320-6.
302 Hallikainen I, Martikainen J, Lin PJ, Cohen J T, Lahoz R, Välimäki T, Hongisto K, Väätäinen S, Vanhanen M, Neumann P J, Hänninen T, Koivisto AM. The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study. Dement Geriatr Cogn Disord Extra 2014(4):494-508.
303 Lieslehto J, Jääskeläinen E, Kiviniemi V, Haapea M, Jones PB, Murray GK, Veijola J, Dannlowski U, Grotegerd D, Meinert S, Hahn T, Ruef A, Isohanni M, Falkai P, Miettunen J, Dwyer DB, Koutsouleris N. The progression of disorder-specific brain pattern expression in schizophrenia over 9 years. NPJ Schizophr 2021:7(1):32.
304 Tiihonen J, Kataja V, Lähteenvuo M, Taipale H. Prolaktiinipitoisuutta suurentavat psykoosilääkkeet ja rintasyöpäriski rekisteritiedon valossa. Duodecim 2022:138(4):296-298.
305 Torvinen-Kiiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study. Aliment Pharmacol Ther 2018:47(8):1135-1142.
306 Laukkanen E, Kuosmanen L, Louheranta O, Vehviläinen-Julkunen K. Psychiatric nursing managers' attitudes towards containment methods in psychiatric inpatient care. J Nurs Manag 2020:28(3):699-709.
307 Laukkanen E, Vehviläinen-Julkunen K, Louheranta O, Kuosmanen L. Psychiatric nursing staffs' attitudes towards the use of containment methods in psychiatric inpatient care: An integrative review. Int J Ment Health Nurs 2019:28(2):390-406.
308 Thomson A, Tiihonen J, Miettunen J, Sailas E, Virkkunen M, Lindberg N. Psychopathic traits among a consecutive sample of Finnish pretrial fire-setting offenders. BMC Psychiatry 2015:15:44.
309 Vaurio O, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Psychopathy and Mortality. J Forensic Sci 2018:63(2):474-477.
310 Lähteenvuo M, Antolin-Concha D, Vattulainen P, Tanskanen A, Taipale H, Tiihonen J. Psychopharmacological treatment, mortality and suicide in bipolar disorder in a Finnish nationwide cohort of 18,018 patients. Psychiatr Fenn 2018:49:10-21.
311 Ojansuu I, Lähteenvuo M, Tiihonen J, Lehti M, Putkonen H. Psychosis and the risk of stranger homicides. Schizophr Bull 2022:3(1):sgac021.
312 Rubio JM, Taipale H, Correll CU, Tanskanen A, Kane JM, Tiihonen J. Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study. Psychol Med 2020:50(8):1356-1367.
313 Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. Lancet Psychiatry 2020:7(9):749-761.
314 Paljärvi T, Tiihonen J, Lähteenvuo M, Tanskanen A, Fazel S, Taipale H. Psychotic depression and deaths due to suicide. J Affect Disord 2023:321:28-32.
315 Tiihonen J, Lehti M, Aaltonen M, Kivivuori J, Kautiainen H, Virta L, Hoti F, Tanskanen A, Korhonen P. Psychotropic drugs and homicide: A prospective cohort study from Finland. World Psychiatry 2015:14(2):245-247.
316 Orsel K, Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease. Eur Neuropsychopharmacology 2018:28(11):1260-1269.
317 Bergström T, Hulkko A, Hartikainen S, Koponen H, Lieslehto J, Jääskeläinen E, Isohanni M. Psykoosilääkehoidon ohjaus voi tehostaa skitsofrenian hoitoa. Duodecim 2022:138(9):787-793.
318 Tiihonen J, Mittendorfer-rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H. Psykoosilääkityksen vaikuttavuus skitsofrenian hoidossa. Duodecim 2017:133(15):1412.
319 Liehu M, Tiihonen M, Taipale H, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S, Koponen M. Psykoosilääkkeiden käyttö on pitkäkestoista Alzheimerin tautia sairastavilla. Dosis 2020:2020(36):6-23.
320 Hallikainen T, Repo-Tiihonen E. Psykoottisen potilaan aggressio - ehkäisy ja hoito. Duodecim 2015:131(15):1361-6.
321 Nummenmaa L, Lukkarinen L, Sun L, Putkinen V, Seppälä K, Karjalainen T, Karlsson HK, Hudson M, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Lauerma H, Tiihonen J. Psykopatian aivomekanismit selviävät. Duodecim 2021:137(9):991-992.
322 Kettunen R, Suvisaari J, Tiihonen J, Ruskoaho H, Huikuri H. Psyykenlääkkeet ja sydän. Duodecim 2020:136(2):1411-8.
323 Tiihonen J, Ojansuu I, Lehti M. Päihdekäyttö ja riski syyllistyä muita vaarantaviin tekoihin. Duodecim 2021:137(22):2461-2466.
324 Kuosmanen A, Liukka M, Aaltonen L-M, Roine RP, Kinnunen M. Pääsyy vai syypää - potilasturvallisuuskulttuuri ratkaisee. Suomen Lääkärilehti 2018:73(8):518-519.
325 Mazumder AH, Barnett J, Isometsä ET, Lindberg N, Torniainen-Holm M, Lähteenvuo M, Lahdensuo K, Kerkelä M, Ahola-Olli A, Hietala J, Kampman O, Kieseppä T, Jukuri T, Häkkinen K, Cederlöf E, Haaki W, Kajanne R, ..., Tiihonen J, et al. Reaction time and visual memory in connection to alcohol use in persons with bipolar disorder. Brain Sci 2021:11(9):1154.
326 Mazumder AH, Barnett J, Isometsä ET, Lindberg N, Torniainen-Holm M, Lähteenvuo M, Lahdensuo K, Kerkelä M, Ahola-Olli A, Hietala J, Kampman O, Kieseppä T, Jukuri T, Häkkinen K, Cederlöf E, Haaki W, Kajanne R, ..., Tiihonen J, et al. Reaction time and visual memory in connection to hazardous drinking polygenic scores in schizophrenia, schizoaffective disorder and bipolar disorder. Brain Sci 2021:11(11):1422.
327 Mazumder AH, Barnett J, Lindberg N, Torniainen-Holm M, Lähteenvuo M, Lahdensuo K, Kerkelä M, Hietala J, Isometsä ET, Kampman O, Kieseppä T, Jukuri T, Häkkinen K, Cederlöf E, Haaki W, Kajanne R, ..., Tiihonen J, et al. Reaction Time and Visual Memory in Connection with Alcohol Use in Schizophrenia and Schizoaffective Disorder. Brain Sci 2021:11(6):688.
328 Puranen A, Koponen M, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects. Schizophrenia (Heidelb) 2023:9(1):34.
329 Taipale H, Tanskanen A, Correll CU, Tiihonen J. Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study. Lancet Psychiatry 2022:9(4):271-279.
330 Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29?823 Patients With Schizophrenia. JAMA Psychiatry 2017:74(7):686-693.
331 Tiihonen J, Tiihonen J. Real-world effectiveness of antipsychotics. Editorial. Acta Psychiatr Scand 2016:134(5):371-373.
332 Puranen A, Koponen M, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Real-world effectiveness of mood stabilizer use in schizophrenia. Acta Psychiatr Scand 2023:147(3):257-266.
333 Lähteenvuo M, Tanskanen A, Taipale H, Hoti F, Vattulainen P, Vieta E, Tiihonen J. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry 2018:75(4):347-355.
334 Lähteenvuo M, Paljärvi T, Tanskanen A, Taipale H, Tiihonen J. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study. Br J Psychiatry 2023:223(4):456-464.
335 Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, Tiihonen J. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients. Addiction 2021:116(8):1990-1998.
336 Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, Tiihonen J. Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction 2022:117(6):1683-1691.
337 Taipale H, Tanskanen A, Correll CU, Tiihonen J. Real-world effectiveness studies of low doses of antipsychotics - Authors' reply. Lancet Psychiatry 2022:9(7):536-537.
338 Koistinaho A, Poranen J, Tanskanen A, Tiihonen J, Taipale H, Lähteenvuo M. Real-world use of pharmacological treatments for incident bipolar disorder: A Finnish nationwide cohort study. J Affect Disord 2023:340:237-244.
339 Putkonen A. Recovery From Cervical Dystonia With Topiramate. J Med Cases 2015:6(8):373-375.
340 Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, Andersen M, Reutfors J. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. J Affect Disord 2017:217:16-23.
341 Tuovinen S. Reduction of Seclusion and Restraint and Hospital Violence During Involuntary Forensic Psychiatric Care. Doctoral dissertation. Kuopio: UEF, 2017. Publications of the University of Eastern Finland. Dissertations in Health Sciences 446. 54., append.
342 Tolppanen A, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PLoS ONE 2017:12(3):e0173450.
343 Taipale H, Tiihonen J. Registry-based studies: What they can tell us, and what they cannot. Eur Neuropsychopharmacology 2021:45:35-37.
344 Tiihonen J, Taipale H, Correll CU. Rejoinder to rejoinder to commentary. Psychol Med 2020:50(16):2812-2813.
345 Terevnikov V, Stenberg J-H, Tiihonen J, Chukhin E, Joffe M, Burkin M, Joffe G. Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-genedation antipsychotics combination trial. Int J Neuropsychopharmacol 2013:16:1661-1666.
346 Kallioniemi E, Kärkkäinen O, Määttä S, Könönen M, Kivimäki P, Kaarre O, Velagapudi V, Kekkonen V, Lehto SM, Laukkanen E, Tolmunen T. Repeated Transcranial Magnetic Stimulation-Induced Motor Evoked Potentials Correlate With the Subject-Specific Serum Metabolic Profile of Creatine. J Clin Neurophysiol 2019:36(3):229-235.
347 Taipale H, Schneider-Thoma J, Pinzón-Espinosa J, Radua J, Efthimiou O, Vinkers CH, Mittendorfer-Rutz E, Cardoner N, Pintor L, Tanskanen A, Tomlinson A, Fusar-Poli P, Cipriani A, Vieta E, Leucht S, Tiihonen J, Luykx JJ. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials. JAMA Psychiatry 2022:79(3):210-218.
348 Fazel S, Paljarvi T. Response to 'Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data': reply from authors. Br J Dermatol 2022:187(3):450-451.
349 Tiihonen J. Response to the editorial on antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res 2018:202:397.
350 Taipale H, Reutfors J, Tanskanen A, Brandt L, Tiihonen J, DiBernardo A, Mittendorfer-Rutz E, Brenner P. Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study. BMC Psychiatry 2020:20(1):232.
351 Chen L, Mittendorfer-Rutz E, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Helgesson M. Risk Factors for Disability Pension among Young Adults Diagnosed with Attention-deficit Hyperactivity Disorder (ADHD) in Adulthood. J Atten Disord 2022:26(5):723-734.
352 Hyttinen V, Taipale H, Tanskanen A, Tiihonen J, Tolppanen AM, Hartikainen S, Valtonen H. Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease. Drugs Aging 2017:34(1):67-77.
353 Reutfors J, Andersson TM, Tanskanen A, DiBernardo A, Li G, Brandt L, Brenner P. Risk factors for suicide and suicide attempts among patients with treatment-resistant depression: nested case-control study. Arch Suicide Res 2021:25(3):424-438.
354 Guinart D, Taipale H, Rubio JM, Tanskanen A, Correll CU, Tiihonen J, Kane JM. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort. Schizophr Bull 2021:47(6):1621-1630.
355 Imtiaz B, Taipale H, Tanskanen A, Tiihonen M, Kivipelto M, Heikkinen A, Tiihonen J, Soininen H, Hartikainen S, Tolppanen A. Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study. Maturitas 2017:98:7-13.
356 Tapiainen V, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study. Acta Psychiatr Scand 2018:138(2):91-100.
357 Saarelainen L, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study. Int J Geriatr Psychiatry 2018:33(4):583-590.
358 Di Thiene D, Helgesson M, Alexanderson K, La Torre G, Tiihonen J, Mittendorfer-Rutz E. Risk of disability pension in first and second generation immigrants: the role of age and region of birth in a prospective population-based study from Sweden. BMC Public Health 2017:17(1):931.
359 Taipale H, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Tolppanen A. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study. Alzheimers Res Ther 2017:9(1):59.
360 Tapiainen V, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease. J Am Geriatr Soc 2020:68(3):595-602.
361 Saarelainen L, Tolppanen A-M, Koponen M, Tanskanen A, Sund R, Tiihonen J, Hartikainen S, Taipale H. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease. J Am Med Dir Assoc 2017:18(1):87.e15-87.e21.
362 Di Thiene D, Helgesson M, Rahman S, Alexanderson K, Tiihonen J, La Torre G, Mittendorfer-Rutz E. Risk of labour market marginalisation among young refugees and non-refugee migrants with common mental disorders. Soc Psychiatry Psychiatr Epidemiol 2021:56(6):1025-1034.
363 Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease. J Alzheimers Dis 2017:56(1):107-118.
364 Taipale H, Tolppanen A, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease. Can Med Assoc J 2017:189(14):E519-E529.
365 Tiihonen J, Tanskanen A, Taipale H. Risk of Treatment Failure: Response to Czobor and Volavka. Am J Psychiatry 2018:175(9):909.
366 Herttua K, Thapa S, Juel Ahrenfeldt L, Paljarvi T. The role of modifiable risk factors in incident cancer in transport, rescue, and security industries. Ann Epidemiol 2023:83:71-77.e1.
367 Gémes K, Taipale H, Björkenstam E, Rahman S, Gustafsson K, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M. The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden. Front Psychiatry 2023:14:1152286.
368 Stenius J. The Rorschach Ego Impairment Index (EII-2) as a predictor of psychotherapy outcome and alliance development. Doctoral dissertation. Jyväskylä: University of Jyväskylä, 2021. JYU Dissertations 378. 74 p.
369 Taipale H, Tanskanen A, Tiihonen J. Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia. Am J Psychiatry 2023:180(5):377-385.
370 Tolppanen A-M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. Pharmacoepidemiol Drug Saf 2017:26(8):875-889.
371 Kuivalainen S, Vehviläinen-Julkunen K, Louheranta O, Putkonen A, Repo-Tiihonen E, Tiihonen J. Seasonal variation of hospital violence, seclusion and restraint in a forensic psychiatric hospital. Int J Law Psychiatry 2017:52:1-6.
372 Laukkanen E, Kuosmanen L, Selander T, Vehviläinen-Julkunen K. Seclusion, restraint, and involuntary medication in Finnish psychiatric care: a register study with root-level data. Nord J Psychiatry 2020:74(6):439-443.
373 Joensuu M. Serotonin transporter availability in major depression. Single photon emission tomography studies on drug-naïve depressed subjects: comparison with healthy subjects, effect of genotype, and follow-up during psychodynamic psychotherapy. Doctoral dissertation. Kuopio: University of Eastern Finland, 2019. Publications of the University of Eastern Finland. Dissertations in Health Sciences 513. 74 p.
374 Tiihonen J, Koskuvi M, Storvik M, Hyötyläinen I, Gao Y, Puttonen KA, Giniatullina R, Poguzhelskaya E, Ojansuu I, Vaurio O, Cannon TD, Lönnqvist J, Therman S, Suvisaari J, Kaprio J, Cheng L, Hill AF, Lähteenvuo M, et al. Sex-specific transcriptional and proteomic signatures in schizophrenia. Nat Commun 2019:10(1):3933.
375 Tuppurainen H, Kivistö P, Repo-Tiihonen E, Tiihonen J. Skitsofrenian Käypä hoito -suosituksen toteutuminen Niuvanniemen sairaalassa. Suomen Lääkärilehti 2014:69(40):2549-2553.
376 Tiihonen J. Skitsofrenian lääkehoito. Duodecim 2019:135(20):2021-7.
377 Lieslehto J, Tiihonen J, Lähteenvuo M, Tanskanen A, Taipale H. Skitsofreniapotilaiden sitoutuminen psykoosilääkitykseen vaihtelee. Duodecim 2022:138(8):731.
378 Cederlöf E, Holm M, Lähteenvuo M, Haaki W, Hietala J, Häkkinen K, Isometsä E, Jukuri T, Kajanne R, Kampman O, Kieseppä T, Lahdensuo K, Lönnqvist J, Männynsalo T, Niemi-Pynttäri J, Suokas K, Suvisaari J, Tiihonen J, Turunen H, et al. Sleep in psychotic disorders: Results from nationwide SUPER Finland study. Schizophr Bull 2022:3(1):sgac011.
379 Vu M, Kettunen R, Tolppanen A, Hartikainen S, Taipale H. Statin discontinuation in persons with and without Alzheimer's disease. Eur J Clin Pharmacol 2022:78(7):1145-1153.
380 Ojansuu I, Putkonen H, Lähteenvuo M, Tiihonen J. Substance Abuse and Excessive Mortality Among Forensic Psychiatric Patients: A Finnish Nationwide Cohort Study. Front Psychiatry 2019:10:678.
381 Cederlöf E, Holm M, Ahti J, Lähteenvuo M, Hietala J, Häkkinen K, Isometsä E, Kampman O, Lahdensuo K, Lönnqvist J, Suvisaari J, Tiihonen J, Wegelius A, Veijola J, Palotie A, Kieseppä T, Niemelä S, Paunio T. Substance use and sleep problems in patients with psychotic disorders. Schizophr Bull Open 2023:4(1):sgac073.
382 Antolín-Concha D, Lähteenvuo M, Vattulainen P, Tanskanen A, Taipale H, Vieta E, Tiihonen J. Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study. J Affect Disord 2020:277:885-892.
383 Helgesson M, Kjeldgård L, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E. Sustainable labour market participation among working young adults with diagnosed attention deficit/hyperactivity disorder (ADHD). SSM Popul Health 2023:23:101444.
384 Lampela P, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Switches and early discontinuations of antidepressant medication in young adults with depression. J Affect Disord 2021:295:1474-1481.
385 Johanson M, Vaurio O, Tiihonen J, Lähteenvuo M. A Systematic Literature Review of Neuroimaging of Psychopathic Traits. Front Psychiatry 2020:10:1027.
386 Tolppanen A-M, Tiihonen M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tiihonen J, Hartikainen S. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study. Drugs Aging 2018:35(11):985-992.
387 Tolmunen T, Suonmaa E, Ruusunen A, Voutilainen S, Lehto S. Tehoavatko omega-3-rasvahapot nuorten mielenterveys- ja oppimishäiriöihin? Suomen Lääkärilehti 2015:70(41):2695-2701.
388 Askola R, Nikkonen M, Putkonen H, Kylmä J, Louheranta O. The Therapeutic Approach to a Patient's Criminal Offense in a Forensic Mental Health Nurse-Patient Relationship-The Nurses' Perspectives. Perspect Psychiatr Care 2017:53(3):164-174.
389 Lehtonen J, Tiihonen J, Joensuu MMO, Lehto SM, Ahola PO, Saarinen PI, Valkonen-Korhonen M, Tolmunen T, Kuikka JT. Toward molecular psychotherapy of depression? In: Levy RA, Ablon JS, Kächele H, eds. Psychodynamic Psychotherapy Research, p. 219-232. New York: Springer, 2012.
390 Wang M, Vaez M, Dorner TE, Tiihonen J, Voss M, Ivert T, Mittendorfer-Rutz E. Trajectories and characteristics of work disability before and after acute myocardial infarction. Heart 2018:104(4):340-348.
391 Rahman S, Filatova S, Chen L, Bjökenstam E, Taipale H, Mittendorfner-Rutz E. Trajectories of antidepressant use and characteristics associated with trajectory groups among young refugees and their Swedish-born peers with diagnosed common mental disordersfindings from the REMAIN study. Soc Psychiatry Psychiatr Epidemiol 2022:57(2):305-317.
392 Helgesson M, Rahman S, Björkenstam E, Gustafsson K, Amin R, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E. Trajectories of labour market marginalisation among young adults with newly diagnosed attention-deficit/hyperactivity disorder (ADHD). Epidemiol Psychiatr Sci 2021:30:e67.
393 Di Thiene D, Mittendorfer-Rutz E, Rahman S, Wang M, Alexanderson K, Tiihonen J, La Torre G, Helgesson M. Trajectories of sickness absence, disability pension and unemployment in young immigrants with common mental disorders. Eur J Public Health 2019:29(6):1055-1062.
394 Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiol Drug Saf 2018:27(6):674-682.
395 Uosukainen H, Kauhanen J, Voutilainen S, Föhr J, Paasolainen M, Tiihonen J, Laitinen K, Onyeka IN, Bell JS. Twelve-year trend in treatment seeking for buprenorphine abuse in Finland. Drug Alcohol Depend 2013:127:207-214.
396 Poranen J, Koistinaho A, Tanskanen A, Tiihonen J, Taipale H, Lähteenvuo M. Twenty-year medication use trends in first-episode bipolar disorder. Acta Psychiatr Scand 2022:146(6):583-593.
397 Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Lavikainen P, Hartikainen S, Taipale H. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease. Ann Med 2017:49(3):230-239.
398 Puranen A, Koponen M, Tanskanen A, Tiihonen J, Taipale H. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia. Eur J Clin Pharmacol 2020:76(5):711-718.
399 Taipale H, Gomm W, Broich K, Maier W, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Haenisch B. Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data. J Am Geriatr Soc 2018:66(6):1123-1129.
400 Hamina A, Paljärvi T, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Use of antipsychotics and antidepressants in first-episode psychotic depression: A nationwide register-based study. Acta Psychiatr Scand 2023:148(5):416-425.
401 Lehti V, Salama E, Niemelä S, Tanskanen A, Gissler M, Suvisaari J, Taipale H. Use of benzodiazepine and related drugs in migrants and Finnish-born persons: a nationwide register-based study. Scand J Public Health 2023:51(8):1222-1230.
402 Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tolppanen AM, Sund R, Tiihonen J, Hartikainen S. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease. Int Clin Psychopharmacol 2017:32(3):135-141.
403 Asikainen J, Louheranta O, Vehviläinen-Julkunen K, Repo-Tiihonen E. Use of coercion prevention tools in Finnish psychiatric wards. Arch Psychiatr Nurs 2020:34(5):412-420.
404 Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Use of debriefing following restrictive practices in forensic psychiatric care. J Forensic Pract 2023:25(1):46-56.
405 Tolppanen A-M, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clin Epidemiol 2013:5:277-285.
406 Tiihonen J. Use of lithium in patients with unipolar depression - Author's reply. Lancet Psychiatry 2017:4(9):663.
407 Tiihonen J. The use of long-acting injectables in early-phase schizophrenia. Lancet Psychiatry 2023:10(7):481-482.
408 Michel SF, Riaz M, Webster C, Hart SD, Levander S, Müller-Isberner R, Tiihonen J, Repo-Tiihonen E, Tuninger E, Hodgins S. Using the HCR-20 to predict aggressive behavior among men with schizophrenia living in the community: Accuracy of prediction, general and forensic settings, and dynamic risk factors. Int J Forensic Ment Health 2013:12(1):1-13.
409 Ahlgrén-Rimpiläinen A, Joelsson P, Kaarre H, Rautanen M, Niinistö K, Lindberg N, Tiihonen J. Vaarallisuuden arviointi - sattuman summaako. Edilex 2020:41:1-30.
410 Repo-Tiihonen E. Vaikeaa psykiatrista sairautta sairastavat ja oikeuspsykiatriset potilaat. Kirjassa: Keränen Tapani, Amos Pasternack, toim. Kliinisen tutkimuksen etiikka: opas tutkijoille ja eettisille toimikunnille, s. 70-73. Helsinki: Duodecim, 2015.
411 Solmi M, Thompson T, Estrade A, ..., Tiihonen J, et al. Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults. J Affect Disord 2023:326:249-261.
412 Lindeman S, Kolari T, Tiihonen J. Valproate and Neuroleptic Malignant Syndrome in an Elderly Patient With Schizoaffective Disorder. Prim Care Companion CNS Disord 2020:22(3):19/02542.
413 Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Violence factors and debriefing in psychiatric inpatient care: A Review . J Psychosoc Nurs Ment Health Serv 2020:58(5):39-49.
414 Kuivalainen S, Vehviläinen-Julkunen K, Putkonen A, Louheranta O, Tiihonen J. Violent behaviour in a forensic psychiatric hospital in Finland: an analysis of violence incident reports. J Psychiatr Mental Health Nurs 2014:21(3):214-8.
415 Tiihonen J. Voisiko luonnon oma säilöntäaine mullistaa psykoosin hoidon? Pääkirjoitus. Duodecim 2013:129:2098-2099.
416 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Turunen H. Voluntary patient safety incidents reporting in forensic psychiatry-What do the reports tell us? J Psychiatr Mental Health Nurs 2022:29(1):36-47.
417 Rossi R, Pievani M, Järvenpää T, Testa C, Koskenvuo M, Räihä I, Kaprio J, Frisoni GB, Rinne JO, Laakso MP, Laakso MP. Voxel-based morphometry study on monozygotic twins discordant for Alzheimer's disease. Acta Neurol Scand 2016:133(6):427-33.
418 Tiihonen J. Vuoden 2022 Matti Äyräpään palkinnon saaja Jari Tiihonen; Lääkehoitojen vaikuttavuustutkimus vie kohti dataohjautuvaa terveydenhuoltoa. Duodecim 2022:138(23):2091-2092.
419 Lindner P, Budhiraja M, Westerman J, Savic I, Jokinen J, Tiihonen J, Hodgins S. White matter correlates of psychopathic traits in a female community sample. Soc Cogn Affect Neurosci 2017:12(9):1500-1510.
420 Sommer IE, Brand BA, Gangadin S, Tanskanen A, Tiihonen J, Taipale H. Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse. Schizophr Bull 2023:49(1):136-143.
421 Vanhanen M, Hakola P, Ilonen T, Tiihonen J. Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Dement Geriatr Cogn Disord 2013:3:10-15.
422 Paakinaho A, Tiihonen M, Koskela H, Koponen M, Tiihonen J , Hartikainen S, Tolppainen A-M. ß2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control Study. Clin Epidemiol 2023:15:695-705.

Julkaisutietokanta 17.6.2024 Publications Data Base 17.6.2024